Abstract:PURPOSE: Exosomes are small membrane vesicles (30-100nm in diameter) secreted by cells into extracellular space. The present study evaluated the effect of chemotherapeutic agents on exosome production and/or release, and quantified the contribution of exosomes to intercellular drug transfer and pharmacodynamics.METHODS: Human cancer cells (breast MCF7, breast-to-lung metastatic LM2, ovarian A2780 and OVCAR4) were treated with paclitaxel (PTX, 2-1000nM) or doxorubicin (DOX, 20-1000nM) for 24-48h. Exosomes were isolated from the culture medium of drug-treated donor cells (Donor cells) using ultra-centrifugation, and analyzed for acetylcholinesterase activity, total proteins, drug concentrations, and biological effects (cytotoxicity and anti-migration) on drug-naïve recipient cells (Recipient cells). These results were used to develop computational predictive quantitative pharmacology models.RESULTS: Cells in exponential growth phase released ~220 exosomes/cell in culture medium. PTX and DOX significantly promoted exosome production and/or release in a dose- and time-dependent manner, with greater effects in ovarian cancer cells than in breast cancer cells. Exosomes isolated from Donor cells contained appreciable drug levels (2-7pmole/106 cells after 24h treatment with 100-1000nM PTX), and caused cytotoxicity and inhibited migration of Recipient cells. Quantitative pharmacology models that integrated cellular PTX pharmacokinetics with PTX pharmacodynamics successfully predicted effects of exosomes on intercellular drug transfer, cytotoxicity of PTX on Donor cells and cytotoxicity of PTX-containing exosomes on Recipient cells. Additional model simulations indicate that within clinically achievable PTX concentrations, the contribution of exosomes to active drug efflux increased with drug concentration and exceeded the p-glycoprotein efflux when the latter was saturated.CONCLUSIONS: Our results indicate (a) chemotherapeutic agents stimulate exosome production or release, and (b) exosome is a mechanism of intercellular drug transfer that contributes to pharmacodynamics of neighboring cells.

Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components

Identificationand Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, Mrna Andmicrorna Components

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.

Exosomes: the Next Generation of Endogenous Nanomaterials for Advanced Drug Delivery and Therapy

Exosomes: biogenesis, biologic function and clinical potential

High-throughput single-cell analysis of exosome mediated dual drug delivery,<i>in vivo</i>fate and synergistic tumor therapy

Engineering exosomes as refined biological nanoplatforms for drug delivery

Exosomes As Drug Carriers for Clinical Application

Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents

Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology

Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases

Mesenchymal stem cells-derived exosomes for drug delivery

The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System

Exosome Theranostics: Biology and Translational Medicine

Targeted exosome-based nanoplatform for new-generation therapeutic strategies

Exosomes as novel bio-carriers for gene and drug delivery

All-in-One Strategy for Downstream Molecular Profiling of Tumor-Derived Exosomes

Isolation and characterization of exosomes for cancer research

Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells

Exosomes from different cells: Characteristics, modifications, and therapeutic applications

Exosomes, a New Star for Targeted Delivery